Mesenchymal Hamartoma of the Liver and DICER1 Syndrome
- PMID: 31067372
- DOI: 10.1056/NEJMoa1812169
Mesenchymal Hamartoma of the Liver and DICER1 Syndrome
Abstract
Mesenchymal hamartoma of the liver (MHL) is a benign tumor affecting children that is characterized by a primitive myxoid stroma with cystically dilated bile ducts. Alterations involving chromosome 19q13 are a recurrent underlying cause of MHL; these alterations activate the chromosome 19 microRNA cluster (C19MC). Other cases remain unexplained. We describe two children with MHLs that harbored germline DICER1 pathogenic variants. Analysis of tumor tissue from one of the children revealed two DICER1 "hits." Mutations in DICER1 dysregulate microRNAs, mimicking the effect of the activation of C19MC. Our data suggest that MHL is a new phenotype of DICER1 syndrome. (Funded by the Canadian Institutes of Health Research and others.).
Copyright © 2019 Massachusetts Medical Society.
Comment in
-
Mesenchymal Hamartoma of the Liver and DICER1 Syndrome.N Engl J Med. 2019 Aug 8;381(6):586-587. doi: 10.1056/NEJMc1907523. N Engl J Med. 2019. PMID: 31390509 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical